Contemporary management of papillary carcinoma of the thyroid gland (Q37411175)

20 August 2017

1 reference

title

Contemporary management of papillary carcinoma of the thyroid gland (English)

1 reference

20 August 2017

main subject

papillary thyroid cancer

1 reference

Michael A Rosenbaum

1

1 reference

20 August 2017

Christopher R McHenry

series ordinal

2

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Expert Review of Anticancer Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

317-329

1 reference

20 August 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Cancer incidence in adolescents and young adults in the United States, 1992-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Thyroid nodules: a review of current guidelines, practices, and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Fine-needle aspiration biopsy of the thyroid: an appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Approach to the patient with a cytologically indeterminate thyroid nodule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Ultrasound in head and neck surgery: thyroid, parathyroid, and cervical lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Controversies in the management of cold, hot, and occult thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Treating differentiated thyroid carcinoma: where do we draw the line?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Management of a solitary thyroid nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

When fine-needle aspiration biopsy cannot exclude papillary thyroid cancer: a therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Improved survival of patients with papillary thyroid cancer after surgical microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Papillary thyroid cancer: controversies in the management of neck metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Central lymph node dissection in differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Clinical review 158: Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Pattern of nodal metastasis for primary and reoperative thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

New therapeutic approaches for metastatic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.3.317

21 January 2018

Identifiers

DOI

10.1586/14737140.9.3.317

1 reference

20 August 2017

1 reference